Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Appoints Kala Shankle Vice President of Regulatory Affairs
HDA announces the appointment of Kala Shankle as Vice President of Regulatory Affairs.
Distributors' Sustainability Efforts: Protecting Patients and the Planet
A new report estimates that the overall health costs of climate change already exceed $820 billion each year. The healthcare sector alone is responsible for nearly 5 percent of worldwide greenhouse gas emissions. According to a December 2020 Health Affairs study, “health damages stemming from U.S. [healthcare] pollution in 2013 [are] on the same order of magnitude as deaths from preventable medical errors.” Unfortunately, many of the most vulnerable communities are impacted by the harmful effects of climate change.
Building a More Climate Resilient Healthcare Supply Chain
Protecting the health of Americans begins with ensuring the well-being of our planet — and healthcare distributors recognize the industry’s responsibility to drive meaningful action on reducing climate change.
Governor Hogan's Signing of Maryland Law Affirms Critical Role of PSAOs and Support for Independent Pharmacies
The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the signing of SB 823 by Maryland Governor Larry Hogan.
HDA Statement on FDA’s 12-digit National Drug Code Final Rule
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s final rule expanding the National Drug Code (NDC) to a 12-digit format.